WHO International Standard for anti-SARS-CoV-2 immunoglobulin
- PMID: 33770519
- PMCID: PMC7987302
- DOI: 10.1016/S0140-6736(21)00527-4
WHO International Standard for anti-SARS-CoV-2 immunoglobulin
Conflict of interest statement
We declare no competing interests.
References
-
- Le TT, Cramer JP, Chen R, Mayhew S. Evolution of the COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19:667–668. - PubMed
-
- WHO First WHO International Standard for anti-SARS-CoV-2 immunoglobulin. 2021. https://www.who.int/groups/expert-committee-on-biological-standardization - PMC - PubMed
-
- Coalition for Epidemic Preparedness Innovations CEPI establishes global network of laboratories to centralise assessment of COVID-19 vaccine candidates. Oct 2, 2020. https://cepi.net/news_cepi/cepi-establishes-global-network-of-laboratori...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
